Skip to main content

Table 3 Dose calculation of trifluridine/tipiracil according to BSA

From: Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer

Dose (mg/m2)

BSA (m2)

Dose in mg (BID)

Tablets per Dose (BID) 15 mg/6.14 mg

Tablets per Dose (BID) 20 mg/8.19 mg

Total daily dose (mg)

35

< 1.07

35

1

1

70

1.07–1.22

40

0

2

80

1.23–1.37

45

3

0

90

1.38–1.52

50

2

1

100

1.53–1.68

55

1

2

110

1.69–1.83

60

0

3

120

1.84–1.98

65

3

1

130

1.99–2.14

70

2

2

140

2.15–2.29

75

1

3

150

≥ 2.30

80

0

4

160

  1. BSA Body surface area. BID twice daily